Tuesday, June 18, 2013
, Hindustan Times
Mumbai, February 14, 2013
First Published: 22:24 IST(14/2/2013)
Last Updated: 22:25 IST(14/2/2013)
Dr Reddy's Q3 net dips 29% to Rs.363.3 cr
Drug maker Dr Reddy's Laboratories on Thursday announced a decline of 29% year-on-year in its net profit to Rs.363.3 crore for the third quarter ended December 2012 against Rs.512.96 crore a year ago.
The company's research and development expenses rose 34% to Rs.203 crore while selling general and administrative expenses were up over 11.5% at Rs.857 crore.
Its shares declined 1% to close at Rs.1,878 on the BSE.
© Copyright © 2013 HT Media Limited. All Rights Reserved.